- 自愿性公告－全资附属公司通过欧盟GMP认证 2024-07-10 00:00:00
- VOLUNTARY ANNOUNCEMENT - WHOLLY-OWNED SU 2024-07-10 00:00:00
- An announcement has just been published 2024-07-10 00:00:00
- 海外监管公告 - 上海君实生物医药科技股份有限公司自愿披露关于全资子公司通过欧盟 2024-07-10 00:00:00
- An announcement has just been published 2024-07-09 00:00:00
- VOLUNTARY ANNOUNCEMENT - JS125 RECEIVED 2024-07-09 00:00:00
- 自愿性公告－JS125获得药物临床试验申请受理通知书 2024-07-09 00:00:00
- 海外监管公告 - 上海君实生物医药科技股份有限公司自愿披露关于JS125获得药物 2024-07-09 00:00:00
- 海外监管公告 - 上海君实生物医药科技股份有限公司关于以集中竞价交易方式回购股份 2024-07-02 00:00:00
- An announcement has just been published 2024-07-02 00:00:00
- An announcement has just been published 2024-06-25 00:00:00
- 海外监管公告 - 上海君实生物医药科技股份有限公司自愿披露关于特瑞普利单抗用于晚 2024-06-25 00:00:00
- VOLUNTARY ANNOUNCEMENT -APPROVAL OF THE 2024-06-25 00:00:00
- 自愿性公告－特瑞普利单抗用于晚期三阴性乳腺癌一线治疗的新适应症上市申请获得批准 2024-06-25 00:00:00
- 2023年股东周年大会、2024年第一次A股类别股东大会及2024年第一次H股类 2024-06-21 00:00:00
- POLL RESULTS OF THE 2023 ANNUAL GENERAL 2024-06-21 00:00:00
- ELECTION OF THE FOURTH SESSION OFTHE BOA 2024-06-21 00:00:00
- 第四届董事会及监事会选举非执行董事及独立非执行董事退任委任职工代表监事 2024-06-21 00:00:00
- LIST OF DIRECTORS AND THEIR ROLES AND FU 2024-06-21 00:00:00
- 董事会成员名单与其角色及职能 2024-06-21 00:00:00
- 海外监管公告 - 上海君实生物医药科技股份有限公司关于选举董事长、副董事长、董事 2024-06-21 00:00:00
- An announcement has just been published 2024-06-21 00:00:00
- 海外监管公告 2024-06-21 00:00:00
- OVERSEAS REGULATORY ANNOUNCEMENT - SHANG 2024-06-21 00:00:00
- 自愿性公告－特瑞普利单抗用于广泛期小细胞肺癌一线治疗的新适应症上市申请获得批准 2024-06-12 00:00:00
- VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE 2024-06-12 00:00:00
- 海外监管公告 - 上海君实生物医药科技股份有限公司自愿披露关于特瑞普利单抗用于广 2024-06-12 00:00:00
- An announcement has just been published 2024-06-12 00:00:00
- 自愿性公告－特瑞普利单抗联合贝伐珠单抗一线治疗晚期肝细胞癌的III期临床研究达到 2024-06-11 00:00:00
- VOLUNTARY ANNOUNCEMENT - PHASE III CLINI 2024-06-11 00:00:00